Drug Delivery System Market Size Report & Global Outlook 2027
[研究报告] 2018 年药物输送系统市场价值为 1,243,111.7 百万美元,预计到 2027 年将达到 2,302,227.2 百万美元;预计 2019 年至 2027 年的复合年增长率为 7.2%。CAGR of 7.2% from 2019 to 2027.
分析师观点:
全球药物输送系统市场主要受到糖尿病、心血管疾病和癌症等慢性疾病患病率上升以及药物输送创新设备制造和开发技术进步的推动。糖尿病是肾衰竭、心脏病发作、失明和中风的主要原因。因此,全球各种慢性疾病患病率的快速增长大大增加了对各种创新治疗药物的需求,从而促进了药物输送系统市场的增长。
快速发展的生物制药行业和各种新型创新药物的开发极大地推动了药物输送系统市场的增长。顶级制药商在治疗不治之症的新药研发方面的投资不断增加,这增加了全球对各种药物输送解决方案的需求。此外,药物输送系统市场的几家顶级市场参与者以及他们采用的产品发布、并购和合作等关键发展战略极大地推动了市场的增长。因此,全球药物和基因输送设备公司的渗透率不断提高,正在推动市场增长。
市场概况:
药物输送系统 (DDS) 是一种配方或设备,它能够将治疗物质引入体内,通过控制药物释放到体内的速率、时间和位置来提高其功效和安全性。药物输送系统在过去 60 年中得到了长足的发展。在过去 12 年中,药物输送技术取得了巨大进步。例如,先进的药物输送系统(如透皮贴剂)能够更有选择性地将药物输送到特定部位,这通常可以更轻松、更准确、总体上减少用药量。医疗和家庭护理环境中还使用了其他药物输送系统,这些系统是根据各种患者的需求而开发的,研究人员也在继续开发新方法。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
药物输送系统市场:
Drug Delivery Systems Market: Strategic Insights
Drug Delivery Systems Market
-
CAGR (2018 - 2027)
7.2%
-
Market Size 2018
US$ 1,243.11 Billion
-
Market Size 2027
US$ 2,302.23 Billion
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- BD Becton Dickinson Company
- Boston Scientific Corporation
- Novo Nordisk A S
- Bausch Health Companies Inc
- Baxter International Inc
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc
- Johnson Johnson Services Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
给药途径(口服、透粘膜、注射、外用、植入和眼部)
分销渠道(医院药房、零售药房和网上药房)
应用(医院和诊所、家庭护理环境及其他)
地理(北美洲、欧洲、亚太地区、中东和非洲、南美洲和中美洲)
Drug Delivery Systems Market: Strategic Insights
-
CAGR (2018 - 2027)7.2% -
Market Size 2018
US$ 1,243.11 Billion -
Market Size 2027
US$ 2,302.23 Billion
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- BD Becton Dickinson Company
- Boston Scientific Corporation
- Novo Nordisk A S
- Bausch Health Companies Inc
- Baxter International Inc
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc
- Johnson Johnson Services Inc
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2018 - 2027)7.2%- 2018 年市场规模
12,431.1 亿美元 - 2027 年市场规模
23,022.3 亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- BD(碧迪公司)
- 波士顿科学公司
- 诺和诺德公司
- 博士伦保健公司
- 百特国际有限公司
- 勃林格殷格翰
- 诺华公司
- 葛兰素史克公司
- 强生服务公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 口服
- 经粘膜
- 注射剂
- 主题
- 可植入
- 眼部
- 医院药房
- 零售药店
- 网上药店
- 医院和诊所
- 家庭护理设置
- 其他的
- 北美
- 欧洲
- 亚太地区
- 中东和非洲
- 南美洲和中美洲
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
市场驱动因素:
慢性病发病率上升推动药物输送系统市场增长
由于药物输送装置有助于输送药物,有利于目标人群更快地康复,因此人们越来越多地采用和倾向于使用先进的药物输送装置。此外,全球癌症、呼吸系统疾病和糖尿病患者数量的增加可能会促进药物输送系统的采用并推动整个市场的发展。根据世界卫生组织 (WHO) 的数据,癌症是全球最大的死亡原因,2020 年约有 1000 万人死于癌症。总体而言,全球癌症发病率和死亡率正在迅速增加。根据 CDC 的数据,2020 年,美国报告了 1,603,844 例新癌症病例,602,347 人死于癌症。乳腺癌、结直肠癌、肺癌、宫颈癌和甲状腺癌在女性中很常见。相比之下,肺癌和前列腺癌在男性中最为常见,占所有男性癌症的近三分之一。癌症负担的增加增加了药物输送装置的采用,为药物输送系统市场的增长做出了重大贡献。
节段分析:
根据应用,药物输送系统市场分为家庭护理环境、医院和诊所和其他。2018 年,医院和诊所部门在药物输送系统市场中占有主要份额。预计在预测期内,家庭护理环境部门将在药物输送系统市场中实现显着增长。医院是一个复杂的组织和机构,通过复杂但专业的科学设备和受过现代医学科学问题教育的训练有素的员工团队为人们提供健康。他们都协调一致,共同致力于恢复和保持健康。医院通过为患有各种疾病的患者群体提供广泛的医疗服务发挥着重要作用。这增加了医院和诊所对药物输送系统的采用。例如,根据疾病控制和预防中心 (CDC) 的数据,2014 年,美国 18 岁或以上的成年人口中共有 720 万人因糖尿病出院。这有望增加控制和治疗慢性病的治疗过程,进而有望增加医院对药物输送系统的使用。
区域分析:
在北美,美国是药物输送系统市场最大的市场。该市场的增长主要得益于糖尿病、哮喘等慢性病患病率的不断上升,主要参与者推出的产品数量不断增加;以及药物输送设备在疾病管理中的使用不断增加。根据美国国家卫生统计中心的数据,到 2023 年,美国预计将出现 190 万例新发癌症病例和 609,820 例癌症死亡病例,并且预计该国的癌症病例还将进一步增加,这预计将增加对各种治疗药物输送系统的需求,因为该地区对癌症治疗的需求相当高,这是由于与该疾病相关的高死亡率,这预计将推动药物输送系统市场的增长。
新产品在该国的推出也将有助于推动药物输送系统市场的增长。例如,2022 年 2 月,美国 FDA 批准了通用 Apokyn(盐酸阿扑吗啡注射液)药筒,用于治疗与晚期帕金森病相关的活动能力减退和其他发作。2021 年 1 月,诺华公司投资 Credence MedSystems,以支持其药物输送系统的开发和扩大。这一举措促进了诺华公司在其注射药物中使用 Credence 技术。同样,2020 年 11 月,Croda International PLC 与辉瑞公司达成协议,为辉瑞的 COVID-19 候选疫苗提供创新的药物输送系统。
此外,2022 年 3 月,Corium 获得美国 FDA 批准,使用 Adlarity 治疗阿尔茨海默病相关的轻度、中度或重度痴呆症患者。透皮贴剂在该国的推出预计将在研究期间推动研究市场的发展。此外,市场参与者的战略举措,例如建立伙伴关系和合作以增加药物输送设备的产量,将带来丰厚的市场增长。例如,2020 年 5 月,美国国防部和美国卫生与公众服务部与 ApiJect Systems America 签订了一份价值 1.38 亿美元的合同,用于“Project Jumpstart”和“RAPID USA”,这将共同努力扩大美国医疗级注射设备的生产能力。
关键球员分析:
药物输送系统市场分析包括 BD、3M、Novo Nordisk A/S、BD、Novo Nordisk A/S、3M、波士顿科学公司、博士伦医疗公司、百特国际公司、勃林格殷格翰、诺华公司、葛兰素史克公司和强生服务公司等参与者。在药物输送系统市场参与者中,3M 和 BD 凭借其提供的多样化产品组合位居前两位。
药物输送系统市场报告范围
报告属性 | 细节 |
---|---|
2018 年市场规模 | 12431.1亿美元 |
2027 年市场规模 | 23022.3亿美元 |
全球复合年增长率(2018 - 2027) | 7.2% |
历史数据 | 2016-2017 |
预测期 | 2019-2027 |
涵盖的领域 | 按给药途径
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
最近的发展:
药物输送系统市场中的公司大量采用并购等无机和有机策略。以下列出了一些近期的关键市场发展:
- 2022 年 6 月,Gufic Biosciences Ltd 首次在印度以实惠的价格推出了一种新型药物输送系统——双室袋。Gufic 的这些即用型双室袋最重要的 USP 之一是它们可以防止污染并保护药物的效力和功效。这些袋子在重构时也易于操作,并且还有助于避免稀释错误,因为药物中含有所需稀释剂的精确数量。
- 2022年2月,武田获得美国FDA批准单剂量预充式注射器(PFS)中的TAKHZYRO(lanadelumab-flyo)注射剂,用于预防12岁及以上成人和儿科患者的遗传性血管性水肿(HAE)发作。PFS即用,与目前的TAKHZYRO小瓶注射剂相比,所需的准备步骤更少,同时还可减少供应和浪费。
Drug Delivery Systems Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 1,243.11 Billion |
Market Size by | US$ 2,302.23 Billion |
Global CAGR | 7.2% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By 给药途径(口服、透粘膜、注射、外用、植入和眼部) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
- BD (Becton Dickinson & Company)
- Boston Scientific Corporation
- Novo Nordisk A/S
- Bausch Health Companies Inc.
- Baxter International, Inc.
- Boehringer Ingelheim
- Novartis AG
- GlaxoSmithKline plc.
- Johnson & Johnson Services, Inc.
- Terumo Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.